10QT
C2 expanded and subtracted 20S Alpha 3 Deletion proteasome core particle in complex with Blm10, Halfmer
This is a non-PDB format compatible entry.
Summary for 10QT
| Entry DOI | 10.2210/pdb10qt/pdb |
| Related | 10GX 10MT 10OG |
| EMDB information | 75163 75294 75334 75393 |
| Descriptor | Proteasome subunit alpha type-1, Proteasome subunit beta type-4, Proteasome subunit beta type-5, ... (14 entities in total) |
| Functional Keywords | 20s proteasome, proteasome regulator, proteasome inhibitor, hydrolase |
| Biological source | Saccharomyces cerevisiae S288C More |
| Total number of polymer chains | 15 |
| Total formula weight | 632377.62 |
| Authors | Walsh Jr., R.M.,Rawson, S.,Fermin Perez, E.,Venclovaite, U.,Hanna, J. (deposition date: 2026-02-02, release date: 2026-07-22, Last modification date: 2026-08-05) |
| Primary citation | Fung, D.,Rawson, S.,Walsh Jr., R.M.,Fermin Perez, E.,Venclovaite, U.,Rajakumar, T.,Velez, B.,Hanna, J. Blm10 and PI31 comprise a failsafe mechanism for proteasome inhibition. Proc.Natl.Acad.Sci.USA, 123:e2611708123-e2611708123, 2026 Cited by PubMed Abstract: Blm10 (PA200 in mammals) is an evolutionarily conserved regulator of the proteasome's core particle (CP), a barrel-shaped complex that houses six individual protease subunits. Despite decades of study, Blm10's function has remained unresolved. Here, we provide structural, biochemical, and genetic evidence that yeast Blm10 inhibits the proteasome and that it does so in cooperation with a second proteasome inhibitor, PI31 (also known as Fub1). Both proteins are highly enriched in CPs with abnormal subunit composition, suggesting that Blm10 and PI31 may function to neutralize aberrant proteasomes. We report an unexpected proteasome configuration in which Blm10's dome-like structure completely encases PI31's N-terminal domain, which sits outside and atop the CP, while PI31's C-terminal domain is present inside the CP, simultaneously inhibiting all six active sites. These Blm10/PI31-bound CP are strongly deficient in degradation of both proteins and small peptides, and loss of both proteins results in strongly synergistic genetic phenotypes in vivo. These data suggest that Blm10 and PI31 constitute a partially redundant failsafe system for proteasome inhibition. PubMed: 42485378DOI: 10.1073/pnas.2611708123 PDB entries with the same primary citation |
| Experimental method | ELECTRON MICROSCOPY (3.4 Å) |
Structure validation
Download full validation report
